These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16123806)

  • 1. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
    Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA
    Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
    Chu J; Ding J; Jeays-Ward K; Price SM; Placzek M; Shen MM
    Development; 2005 Dec; 132(24):5539-51. PubMed ID: 16291788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
    Normanno N; De Luca A; Bianco C; Maiello MR; Carriero MV; Rehman A; Wechselberger C; Arra C; Strizzi L; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Jan; 198(1):31-9. PubMed ID: 14584041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
    FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.
    Kenney NJ; Adkins HB; Sanicola M
    J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):133-44. PubMed ID: 15300009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
    Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.
    Minchiotti G
    Oncogene; 2005 Aug; 24(37):5668-75. PubMed ID: 16123800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C; Whitman M
    Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
    Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
    Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evolving web of signaling networks regulated by Cripto-1.
    Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
    Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto localizes Nodal at the limiting membrane of early endosomes.
    Blanchet MH; Le Good JA; Oorschot V; Baflast S; Minchiotti G; Klumperman J; Constam DB
    Sci Signal; 2008 Nov; 1(45):ra13. PubMed ID: 19001664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cripto monoclonal antibodies.
    Hu XF; Xing PX
    Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
    Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
    Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.